Abstract:In line with the complexity of disease networks, diverse combination therapies have been demonstrated potential in the treatment of different patients with complex diseases in a personal combination profile. However, the identification of rational, compatible and effective drug combinations remains an ongoing challenge. Based on a holistic theory integrated with reductionism, Fangjiomics systematically develops multiple modes of array-designed combination therapies. We define diverse "magic shotgun" vertical, … Show more
“…GD2 group had normal glucose tolerance. believe that this is the ultimate goal of Fangjiomics [8][9][10][11] , which takes advantage of TCM to promote systematic reactions in the human body to actually cure the disease and not only treat the symptoms. In fact, other groups have followed the guidance of Fangjiomics to explore the molecular actions of the Traditional Chinese Herbal Formula for the treatment of diabetes [13] .…”
Section: Discussionmentioning
confidence: 99%
“…Although the ultimate goal of both TCM and Western medicine is to cure diseases, there are fundamental and conceptual differences between TCM and Western medicine. TCM treats the human body and disease as an integrated system, and the crosstalk among different organs and the interplay of various symptoms are all taken into consideration when a TCM doctor diagnoses patients [8][9][10][11] . In TCM terminology, diabetes is called Xiao-ke, which is caused by an improper diet, emotional disturbances and, most critically, Yin deficiency, in which patients exhibit fatigue, weakness and tiredness.…”
Graves' disease (GD) is the leading cause of hyperthyroidism, and the majority of GD patients eventually develop disorders of glucose handling, which further affects their quality of life. Yangxin Tongmai formula (YTF) is modified from a famous formula of traditional Chinese medicine for the treatment of cardiovascular diseases. In this study we investigated the potential effects of YTF in the treatment of pediatric GD patients with impaired glucose tolerance. Forty pediatric GD patients and 20 healthy children were recruited for this clinical study. Based on the glucose tolerance, the GD patients were divided into two groups: 20 patients displayed impaired glucose tolerance, while the other 20 patients displayed normal glucose tolerance. YTF was orally administered for 60 days. YTF administration significantly ameliorated the abnormal glucose tolerance and insulin sensitivity in the GD patients with impaired glucose tolerance. To determine the molecular mechanisms of this observation, the number of plasma insulin receptors was determined by ELISA. Before treatment, the fasting and postprandial levels of the insulin receptor were significantly lower in patients with impaired glucose tolerance compared with those in patients with normal glucose tolerance and healthy children. After YTF treatment, both the fasting and the postprandial circulating insulin receptor levels were upregulated, and close to those in healthy children. Therefore, YTF is a potential effective treatment to enhance glucose handling in GD children with impaired glucose tolerance.
“…GD2 group had normal glucose tolerance. believe that this is the ultimate goal of Fangjiomics [8][9][10][11] , which takes advantage of TCM to promote systematic reactions in the human body to actually cure the disease and not only treat the symptoms. In fact, other groups have followed the guidance of Fangjiomics to explore the molecular actions of the Traditional Chinese Herbal Formula for the treatment of diabetes [13] .…”
Section: Discussionmentioning
confidence: 99%
“…Although the ultimate goal of both TCM and Western medicine is to cure diseases, there are fundamental and conceptual differences between TCM and Western medicine. TCM treats the human body and disease as an integrated system, and the crosstalk among different organs and the interplay of various symptoms are all taken into consideration when a TCM doctor diagnoses patients [8][9][10][11] . In TCM terminology, diabetes is called Xiao-ke, which is caused by an improper diet, emotional disturbances and, most critically, Yin deficiency, in which patients exhibit fatigue, weakness and tiredness.…”
Graves' disease (GD) is the leading cause of hyperthyroidism, and the majority of GD patients eventually develop disorders of glucose handling, which further affects their quality of life. Yangxin Tongmai formula (YTF) is modified from a famous formula of traditional Chinese medicine for the treatment of cardiovascular diseases. In this study we investigated the potential effects of YTF in the treatment of pediatric GD patients with impaired glucose tolerance. Forty pediatric GD patients and 20 healthy children were recruited for this clinical study. Based on the glucose tolerance, the GD patients were divided into two groups: 20 patients displayed impaired glucose tolerance, while the other 20 patients displayed normal glucose tolerance. YTF was orally administered for 60 days. YTF administration significantly ameliorated the abnormal glucose tolerance and insulin sensitivity in the GD patients with impaired glucose tolerance. To determine the molecular mechanisms of this observation, the number of plasma insulin receptors was determined by ELISA. Before treatment, the fasting and postprandial levels of the insulin receptor were significantly lower in patients with impaired glucose tolerance compared with those in patients with normal glucose tolerance and healthy children. After YTF treatment, both the fasting and the postprandial circulating insulin receptor levels were upregulated, and close to those in healthy children. Therefore, YTF is a potential effective treatment to enhance glucose handling in GD children with impaired glucose tolerance.
“…Combination therapy with multi-drug regimen as an integrated intervention of several pharmacological compounds that interact with multiple targets, rather than monotherapy using a single compound that targets at a single molecule, is a common strategy for combating complex disease in both Western and traditional Chinese medicine (TCM) [1][2][3] . But each is based on different mechanistic principles.…”
mentioning
confidence: 99%
“…The ingredients in a Fangji were thus composed according to the quaternity of Jun (monarch), which targets at the major etiological mechanisms, Chen (minister), which targets at the secondary etiological mechanisms, Zuo (assistant or associate), which targets at the associated factors to facilitate the therapeutic effects or reduce the adverse effects, and Shi (guide), which guides and orchestrates the targets [4] . Therefore, TCM Fangji combination therapy has embodied many principles of modern systems biology and omic theories [2,3] . The therapeutic effects of TCM Fangji rely on the integrated whole function through compatibility of the drugs in the multi-drug regimen of Fangji [2] .…”
“…Wang et al summarized the recent investigations on the anticancer activities and possible molecular targets of the Compound Kusen Injection, and then hypothesized that altering gene regulation in several pathways including Wnt signaling pathway might be involved in the underlying mechanisms [9] . To summarize the targets distribution of Fangjis, Liu and Wang defined multiple modes of array-designed combination therapies of Fangjiomics, such as "magic shotguns", vertical, horizontal, focusing, siege and dynamic arrays according to hits on targets, pathways or networks [10] . Also included in this Special Issue are six original research articles that delineate the systematic and network approaches of Fangjiomics on several popular Zheng-hous or Fangjis, which are commonly used in TCM practice.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.